Table: Wakamoto Pharm - 9-MTH parent results

Wakamoto Pharmaceutical

02/02/2023 06:00

Feb 2 (Reuters)- 
             Wakamoto Pharmaceutical Co Ltd 
             PARENT-ONLY FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 9 months ended      9 months ended       Year to 
                Dec 31, 2022        Dec 31, 2021     Mar 31, 2023 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales             6.27                6.27             8.50     
                 (+0.0 pct)                           (+1.4 pct)  
  Operating        33 mln            loss 95 mln        90 mln    
  Recurring        128 mln           loss 57 mln        110 mln   
                                                      (+52.2 pct) 
  Net              110 mln             210 mln          150 mln   
                 (-47.5 pct)                          (-37.1 pct) 
  EPS             3.18 yen            6.06 yen         4.32 yen   
  Ann Div                                NIL                      
  -Q2 div            NIL                 NIL                      
  -Q4 div                                NIL                      
  
  NOTE - Wakamoto Pharmaceutical Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4512.T